The US FDA has suspended trials of Kezar Life Sciences’ drug for the treatment of lupus 

The US Food and Drug Administration has banned clinical trials of the drug Kezar Life Sciences, said the company, which is testing an experimental drug to treat lupus.

Teile diesen Beitrag: